免疫治疗、化疗被证实存在一定疗效。分子靶向研究是恶性黑色素瘤治疗的新趋势。
The immunotherapy and chemotherapeutics confirmed existence certain curative effect, Molecular staging and targeted therapy may will be the new tendency in future.
首先，研究人员不知道人类成血干细胞同样的分子是否刚好是治疗的靶向细胞。
First, the researchers don't know whether the same molecule on human blood-forming stem cells would be the right one to target with a therapy.
这方面的进展代表着在这个复杂疾病处理上的一个突破。肝癌具有多药耐药性，但研究证明这种分子靶向对其治疗是有效的。
This advancement represents a breakthrough in the management of this complex disease, and proves that molecular targeted therapies can be effective in this otherwise chemo-resistant tumor.
本文着重评述了近年来不同结构类型的DNA靶向分子与DNA相互作用研究方面的进展。
In this article, recent advances in the studies of interactions between DNA and DNA targeting molecules with different structures are reviewed.
最近，新的靶向分子得到了确认，针对肝癌治疗的多种靶向因子正处于研究中。
Recently, new molecular targets have been confirmed and various targeted agents are now being investigated for the treatment of HCC.
深入研究肿瘤血管异质性分子对于肿瘤诊断、血管靶向治疗等具有重要意义。
And it is significant for the diagnosis of tumors and the therapy targeting tumor vasculatures to research the heterogeneous molecules further.
联合使用靶向性氙生物大分子探测器，我们应该可以研究肺中的气体交换，探测最早阶段的癌细胞。
Used in combination with a target-specific xenon biomolecular sensor, we should be able to study the gas-exchange in the lung and detect cancerous cells at their earliest stage of development.
分子靶向治疗是近年来肿瘤治疗的一个闪光点，凭着它的特异性和有效性，目前已成为国内外肿瘤治疗的研究热点。
Molecularly targeted therapy is a highlight of new pattern for cancer treatment, which has been a Research hot spot in recent years with its Specificity and Efficacy.
研究显示，PDCD4基因在肿瘤治疗中作为一种分子治疗靶向的可能性。
These studies indicated a potential value of PDCD4 as a molecular target in cancer therapy.
png研究人员还发现，抗癌蛋白TRAIL可以作为靶向分子直接绑定到癌细胞的表面，这一点在之前还没有被证明。
The researchers also found that an anticancer protein, TRAIL, can serve as an active targeting molecule to bind directly to the surface of cancer cells, which had not been demonstrated previously.
而对于食管癌的分子靶向治疗，目前尚处于萌芽阶段，也是食管癌治疗研究的重点，并具有广阔的前景。
The molecular targeted therapy for esophageal cancer, still in its infancy, is also an important area of the study in future esophageal cancer treatment.
本文针对肝癌的分子靶向治疗的研究进展做一综述。
This review attempts to concisely summarize the molecularly targeted therapy of advanced hepatocellular carcinoma.
本研究结果可以为GCT的预后判断及分子靶向药物的开发提供实验依据。
The research results may provide experimental basis for the prognosis of GCT and the molecular targeted therapeutic drugs development.
分子靶向药物联合应用及与细胞因子或传统化疗药物的联合应用正在研究中。
The study evaluating combinations of different molecular targeted agents and molecular targeted agents combined with cytokine or chemotherapy agents are ongoing.
KRAS基因突变在恶性肿瘤组织中频发，可预测非小细胞肺癌分子靶向治疗的疗效和预后，针对RAS基因的分子抑制剂研究仍处于初级阶段。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
本文主要对肺癌的分子靶向治疗研究进展进行概括总结。
This article will summarize the new development of molecular targeted therapies currently in lung cancer.
生物可降解型高分子载体控制释放药物和生物可降解型高分子载体靶向药物是近年来高分子药物研究的重点。
Biodegradable macromolecule carried controlled drug releasing and biodegradable macromolecule carried targeted drug delivery are the focus of recent investigation in macromolecular medicine.
在此基础上，概述了磁性高分子微球在磁性塑料、固定化酶、细胞分离和靶向药物等领域的应用情况，并对磁性高分子微球的未来研究方向进行了展望。
The applications of magnetic polymer microspheres in magnetic plastics, enzyme immobilization, cell separation and target drug etc. were also summarized, and the prospects of this field were analyzed.
英国利兹大学的一项研究已经发现，通过靶向一个分子帮助细胞恢复他们的DNA，可能为一些侵袭性脑肿瘤带来新的治疗方式。
Targeting a molecule that helps cells repair their DNA could lead to a new treatment for some aggressive brain tumours, a University of Leeds study has found.
随着分子生物学研究的进展，表皮生长因子受体抑制剂、血管内皮生长因子抑制剂等分子靶向药物的研究成为热点之一。
With the advancement of the study of molecular biology, the research of the molecular targeted drugs such as EGFR inhibitor and VEGF inhibitor, become one of the hot spots.
研究人员认为这个理论已经得到充分的证明，其他的肿瘤细胞只需要利用不同的靶向分子，只不过研究还处在初级阶段而已。
Rozhkova said that a proof of concept is demonstrated, and other cancers can be treated as well using different targeting molecules, but research is in the early stages.
由于GIST分子靶向治疗的成功，GIST越来越受到人们的关注，因此，有必要对GIST的临床病理研究作一概述。
Along with the success of targeted therapy of GIST, the disease was paid more attention. Therefore, a review of the clinical pathological study...
近年来国际上对其治疗的研究已主要集中在分子水平上，如抗肿瘤坏死因子（TNF） 抗体，T细胞靶向药物等。
Recently some new medicines as anti-TNF bodies and T cell directed agents are used in treatment.
目的通过研究不同相对分子质量n -琥珀酰壳聚糖与肿瘤细胞的亲和性，筛选出最佳靶向制剂载体。
OBJECTIVE to investigate the affinity of N-succinyl-chitosan samples to cancer cells, and select the best one as the drug targeting carrier.
目的通过研究不同相对分子质量n -琥珀酰壳聚糖与肿瘤细胞的亲和性，筛选出最佳靶向制剂载体。
OBJECTIVE to investigate the affinity of N-succinyl-chitosan samples to cancer cells, and select the best one as the drug targeting carrier.
应用推荐